
Co-author of LMHR study protocol says the design could not detect plaque progression
Louis paraphrases Dr. Spencer Nadolsky, who helped write the LMHR (keto hypercholesterolemia) study protocol, saying it enrolled only extremely healthy people with no diabetes, prediabetes, atherosclerosis, smoking, overweight or high hs-CRP and perfect blood pressure. Because soft plaque takes years to form even with very high LDL, little progression was likely after one year; enrolling people with existing atherosclerosis would have been more informative. The study's absence of progression should therefore not be read as proof of safety.
